| Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children MR Capeding, S Teshome, T Saluja, KA Syed, DR Kim, JY Park, JS Yang, ... Vaccine 36 (26), 3794-3801, 2018 | 39 | 2018 |
| Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine SJ An, YK Yoon, S Kothari, DR Kim, JA Kim, N Kothari, E Lee, TH Park, ... Vaccine 30 (6), 1023-1028, 2012 | 30 | 2012 |
| Physico-chemical properties of Salmonella typhi Vi polysaccharide–diphtheria toxoid conjugate vaccines affect immunogenicity SJ An, YK Yoon, S Kothari, N Kothari, JA Kim, E Lee, DR Kim, TH Park, ... Vaccine 29 (44), 7618-7623, 2011 | 29 | 2011 |
| A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi S Kothari, N Kothari, JA Kim, E Lee, YK Yoon, SJ An, C Jones, WS Choe, ... Vaccine 31 (42), 4714-4719, 2013 | 23 | 2013 |
| A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi N Kothari, S Kothari, YJ Choi, A Dey, DE Briles, DK Rhee, R Carbis Vaccine 33 (6), 783-788, 2015 | 20 | 2015 |
| Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A S Kothari, JA Kim, N Kothari, C Jones, WS Choe, R Carbis Vaccine 32 (21), 2457-2462, 2014 | 18 | 2014 |
| Development of an efficient and scalable method for processing and purification of Vi capsular polysaccharide S Kothari, N Kothari, E Lee, JA Kim, SJ An, YK Yoon, GW Smith, R Carbis Procedia in Vaccinology 2 (1), 78-81, 2010 | 16 | 2010 |
| Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein N Kothari, KR Genschmer, S Kothari, JA Kim, DE Briles, DK Rhee, ... Vaccine 32 (43), 5755-5760, 2014 | 10 | 2014 |
| Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine SJ An, JS Woo, MH Chae, S Kothari, R Carbis Vaccine 33 (13), 1614-1619, 2015 | 9 | 2015 |
| Spectroscopic characterisation of a series of Salmonella Typhi Vi-diphtheria toxoid glycoconjugate antigens differing in polysaccharide-protein ratio C Jones, SJ An, YK Yoon, S Kothari, S Sahastrabuddhe, R Carbis Journal of Pharmaceutical and Biomedical Analysis 181, 113100, 2020 | 7 | 2020 |
| Identification of collaborative cross mouse strains permissive to Salmonella enterica serovar Typhi infection KR Alugupalli, S Kothari, MP Cravens, JA Walker, DT Dougharty, ... Scientific Reports 13 (1), 393, 2023 | 5 | 2023 |
| OL-072 Process development of an affordable bivalent conjugate vaccine against the two major causes of enteric fever, Salmonella typhi and Salmonella paratyphi A S Kothari, JA Kim, R Carbis International Journal of Infectious Diseases, S40, 2011 | 3 | 2011 |
| Collaborative Cross mice are permissive to Salmonella enterica serovar Typhi infection K Alugupalli, S Kothari, M Cravens, J Walker, D Dougharty, G Dickinson, ... | | 2022 |
| A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi (Vol 31, pg 4714, 2013) S Kothari, N Kothari, JA Kim, E Lee, YK Yoon, SJ An, C Jones, WS Choe, ... Vaccine 32 (30), 3877-3877, 2014 | | 2014 |
| Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine. ASJ An SoJung, YYK Yoon YeonKyung, S Kothari, KDR Kim DeokRyun, ... | | 2012 |
| Physico-chemical properties of Salmonella typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity. ASJ An SoJung, YYK Yoon YeonKyung, S Kothari, N Kothari, ... | | 2011 |
Neha KothariPfizer在 pfizer.com 的电子邮件经过验证
